Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
 Your new post is loading...
Your new post is loading...
Scoop.it!
Due to our deep-rooted pharma commercial expertise, IMS Health offers clients unparalleled pharmaceutical business process outsourcing capabilities. Via rob halkes 
No comment yet.
Sign up to comment
Scoop.it!
New York City-based ZocDoc (@ZocDoc) has launched a new patient check-in feature for users of its online physician search engine and appointment booking service. Via Guus van den Brekel
Scoop.it!
Interview with Al Shar talks about his vision for mobile health and the role the Foundation can play moving forward.
Via uri goren
Scoop.it!
Speaking of Sanofi...check out the Sanofi US corporate blog!
Scoop.it!
A @philapharm RT @mobilehealth: iHealth smartphone-enabled devices to integrate with EHR http://t.co/I0ToY96a #healthapps @MobiHealthNews...
Scoop.it!
Cegedim’s annual industry survey, 2012 US Pharma Insights, reveals that while more pharma companies are using social media and mobile platforms to enhance their sales and marketing initiatives, budgets did not reflect an increase in social media spend. Internal alignments are also shifting, with more people citing executive management as the main sponsors of investment in new technology platforms rather than traditional IT departments.
Pharma employees have more readily embraced key social media venues in the past year, with 96% of participants present on LinkedIn, 70% on Facebook, and 37% on Twitter, compared to 54%, 32%, and 9% in 2011, respectively. Together, they account for an average 36% increase in use of these platforms. While social media use among survey respondents have shot up, budgets fail to reflect an enthusiasm for such exploits: 29% of companies spent less than 5% of their budgets on social media in 2011 and 50% have spent only that much in 2012; spend in the 5-10% range increased by a mere one percent and declined in the 10% and beyond range by an average of 4.5%. Overall, it means that while more companies are participating in the medium, as companies engage they tend to spend the same or less.
Another interesting find in this survey is that companies have undergone a marked shift in priorities. Compared with 29% the previous year, 55% of participants cite strategy/business planning/business development as the primary driver of business model and process change. Marketing/brand teams, commercial operations and regulatory/compliance all saw declines in the neighborhood of 11% in terms of leading the pace of change. This aligns with executive management being seen as the primary driver of technology changes, growing from 28% to 46% in 2011, in contrast to IT’s decline in influence, sliding from 28% to 18%. What is clear here is that the imperative for a more robust technological infrastructure comes from those with the primary role in allocating capital investment and assessing budget spend.
Scoop.it!
Learn which pharmaceutical companies have taken the leap and are using Pinterest for corporate reputation, recruitment and disease awareness.
Since I first wrote about Pinterest the site has continued to garner headlines for its growth and new offerings. If you aren’t familiar with the social network Pinterest, it’s a “virtual pinboard.” It allows users to organize and share Internet content (typically images) by pinning it to virtual boards. Accounts can be linked to Facebook and Twitter to share Pinterest activity via these social networks.The demographics have stayed consistent–it skews heavily to females age 25-34 in the Midwest. About 2/3 of users are women, and half have children. It’s the sixth most popular social network, with 27M unique visitors per Nielsen. - Pharma on Pinterest: - Astra Zeneca Jobs is “intended to highlight - AZ’s culture, people & opportunities.” They have 120 followers. - Bayer has 226 followers, with boards on topics ranging from innovation to Bayer advertising to gardening. - Johnson & Johnson have posted their logo and reserved the URL. Despite the lack of content, they have 113 followers. - Boehringer Ingelheim sets expectations nicely by including terms of use explaining that they have the right to remove any postings, as “we can’t risk unmonitored or unverified medical advice being published.” The 101 followers can view pins on company history, lung cancer, COPD and stroke. - Novo Nordisk, with 163 followers, has boards on World Haemophilia Day and World Diabetes Day along with some patient stories. Pharma on Pinterest Via rob halkes
Scoop.it!
As a new clinic or medical practice getting your name, brand, and website out to the community can happen in many different ways. Traditional marketing.
Via Dean Berg
Scoop.it!
![For Health Answers, People Consult the Internet Over Doctors [STUDY] | E-SANTÉ : COMPRENDRE. RELIER. TRANSFORMER. | Scoop.it](https://img.scoop.it/jqDXoOYb-Ndv8HXHu8px5Tl72eJkfbmt4t8yenImKBVvK0kTmF0xjctABnaLJIm9)
Are you a bit shy when it comes to asking your physician personal health questions? If so, you're not alone, according to a survey by Pearl.com.
Via Kirrina
Scoop.it!
How the phone in your pocket could help power a revolution in healthcare that will allow your doctor to spot problems – and intervene – no matter where you are in the world.
Dr Leslie Saxon wants to be able to measure anybody’s heartbeat, no matter where they are in the world.
The cardiologist, from the University of Southern California, specialises in the diagnosis and treatment of heart disease using wearable and implanted devices.
She believes that networked gadgets, such as an iPhone fitted with a heartrate monitor, could be the start of a revolution in healthcare that will allow your doctor to spot problems - and intervene – even if they are thousands of miles away. Via Thibaud Guymard, Antoine POIGNANT, MD
Scoop.it!
by Jane Sarasohn-Kahn, MA (Econ.), MHSA, Member, HIMSS eConnecting with Consumers – Social Media Task Force Chronic disease accounts for $3 in every $4 of health spending in the U.S. Four lifestyle...
Via Dan Baxter
Scoop.it!
Healthcare Technology (@healthtechzone Thanks for mentioning: "Mobile Applications - Clearly a Revolution in Healthcare" #mhealth #hcsm http://t.co/tiyOrkAz...)...
Via Gilles Jourquin
|
Scoop.it!
PharmExecBlog summed up Cegedim’s "2012 US Pharma Insights" survey this way: "while more pharma companies are using social media and mobile platforms to enhance their sales and marketing initiatives, budgets did not reflect an increase in social media spend" (see Companies Trim Social Media Spending, While Platform Priorities Shift). Andrew Spong "rescooped" this under the headline "Pharma employee use of social platforms up by 36 percent in 2012." Once again, we are fed data about pharmaceutical companies that (1) have very little basis in reality, and (2) are not specific to traditional pharmaceutical companies that manufacture and market prescription small molecule and biologics. The title of Cegidim's survey and white paper summary ("2012 US Pharma Insights") is itself misleading because the majority of respondents are NOT employed by traditional pharmaceutical companies. Via Richard Meyer
Scoop.it!
Scoop.it!
A new survey shows that about one in four physicians uses social media daily or multiple times a day to scan or explore medical information, and 14 percent use social media each day to contribute new information, according to an oncologist.
Via Dean Berg
Scoop.it!
"Dear friends, employees, and pharma aficionados..."That's how Stacy Burch, Director, Corporate Reputation and Digital Communications, at Sanofi US, began the first post ("Speaking of Blogs..."; here ) to her company's new blog "Speaking of...
Scoop.it!
While mHealth is growing quickly, consumers aren't embracing it at the same rate.
Scoop.it!
Les médicaments innovants sont de plus en plus rares et de plus en plus coûteux. L'industrie pharmaceutique cherche à compenser sa faible capacité d'innovation et son aversion au risque en recherchant les nouvelles molécules à l'extérieur et en délocalisant leurs fonctions techniques en Asie. Leurs bases de données constituent pourtant de véritables champs pétrolifères. Sauront-ils les exploiter ? Via Alexandre DUBOIS
Scoop.it!
Aetna CEO Mark Bertolini’s opening keynote set the tone for an mHealth Summit with a notable, but not unexpected, payer presence. In 2010 MobiHealthNews wrote about the changing role of the payer in health care, predicting that payers would soon help drive the mobile health agenda. The 2012 summit confirmed that prediction may soon be proven true. Via Sam Stern, dbtmobile
Scoop.it!
One out of every three adults in the US will buy a digital health product of some kind in the next year, Gary Shapiro, the CEO of the Consumer Electronics Association (CEA), said — citing data from an upcoming CEA survey — during his luncheon keynote at HIMSS’ mHealth Summit this week.
Over the course of this past year the consumer/patient-facing digital health conversation shifted from a predominantly direct-to-consumer market to one that might leverage traditional healthcare channels. Among the drivers that steered the industry back toward the patient-provider relationship: the prospect of physicians prescribing apps, the importance of integrating data from mobile health programs with EHRs and other systems, and the push for patient engagement from forthcoming meaningful use requirements.
Health apps and smartphone-enabled medical devices today, which Vinod Khosla (Khosla Ventures) described as “clumsy point solutions”, are just version 1.0 of digital health, he said. This is just the beginning and some of the consumer-driven services today will quickly make their way into the healthcare system.
Consumer health and provider-driven digital health initiatives, of course, will grow up together in parallel. Each can help drive the other in their own way.
“There are really two models for how the world works: the cathedral and the bazaar model,” Khosla explained. “Bazaars evolve much faster than cathedrals do — often because people leave cathedrals to join the bazaar. You can also be in a cathedral and help the bazaar evolve faster than any cathedral could on its own.”
Scoop.it!
Les technologies de simulation, technologies de réalité virtuelle ou de réalité augmentée, trouvent déjà de nombreuses applications en santé, et ce marché devrait être porteur dans les années à venir si certains obstacles ont levés.
Via nathalie Bissot-Campos
Francis Chatot's curator insight,
December 16, 2012 2:43 AM
Clair, concis et qq liens utiles... Merci à Laurent Gout pour ce "scoop" :)
Scoop.it!
Pharma: from (e)detailing to physician and patient excellence, a new commercial approach.
The demand for a new commercial model in Pharma is striking. Lots of talk about social media, KAM, gaming, mobile and all kinds of excellences: customer, sales and marketing. But what's the roadmap starting from the current situation of pharma's commercial business approach, to get to a new commercial relationship for the (local affiliates) of the pharmaceutical industry to its very customers? I invite you to the scetch of this. I made this outline on the basis of having gone that road and now look back on the (very) positive results. Hold yourself to your seat: it might feel like a roller coaster! But doesn't just make that all the fun? You may challenge me ;-) but thanks for your attention anyway!
Rob
Via rob halkes
Scoop.it!
Scoop.it!
In 2006, Pew Research Forum discovered that 80% of American adults used the Internet to research medical information. By 2011, data (separately) compiled by Frost and Sullivan and QuantiaMD showed between 87% to 90% of physicians used at least one social media site for personal reasons, with a further 67% to 75% opting for more professional postings.
Via Philippe Marchal
|
